about
Clinical applications of mesenchymal stem cellsNeural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challengesIn vivo depletion of lymphotoxin-alpha expressing lymphocytes inhibits xenogeneic graft-versus-host-diseaseGraft versus host disease: New insights into A2A receptor agonist therapyExtracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccinationMesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.Pain Management for Children during Bone Marrow and Stem Cell Transplantation.Association of HLA-G low expressor genotype with severe acute graft-versus-host disease after sibling bone marrow transplantation.Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin.Mesenchymal stem cells targeting the GVHD.Immunoregulatory gene polymorphisms and graft-versus-host disease.Immunoregulation of GVHD by triggering the innate immune system with CpG.The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization.Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study.Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease.Eosinophilia predicts better overall survival after acute graft-versus-host-disease.
P2860
Q21198864-60685A94-AD9A-4C8C-88AA-53FC8A5DF6BAQ26775932-1FA7182F-AAA4-43E7-B825-6BE26584E968Q27307168-257C77C7-8EA8-465E-BBF6-B70227595B80Q28080809-2182568A-0E96-478B-A599-527B8808BE4AQ34927696-CEEE769C-3750-4F92-9094-015E1A794FCFQ35203695-22E0339F-7C8A-4EBC-B951-A2B35DF57701Q35220429-989CCC40-2DCC-408A-87A8-75EE226EE5DAQ35928084-EDE555B7-B578-4ABF-B620-FC9226C55746Q36841859-4AC9EC9A-F504-403A-8987-DFB1C6321BE4Q37566315-BAFD7CB9-7CCD-4455-8654-59BE52E1E510Q37755281-19BD0C91-FC9A-4447-896E-A3451F2FB405Q37810081-D9299961-DCCD-4581-8569-95D01F64EAFFQ38442767-F5C6EB84-E7BF-41F0-9D0C-42594CE35ECAQ38453666-76D0CBD4-0F1D-4EB1-A48D-73E00A355292Q38682125-4B9381A2-994E-41FF-BFF1-88BC71DDC0E6Q38839140-B2DB3F69-9D46-4906-B297-A22D70D2A5FAQ43563744-B9F21C7C-300A-4C7B-922C-E260D74ED058Q50605868-AFE10B39-3B54-4005-889F-1152B1146AAA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention and treatment of acute GvHD.
@en
Prevention and treatment of acute GvHD.
@nl
type
label
Prevention and treatment of acute GvHD.
@en
Prevention and treatment of acute GvHD.
@nl
prefLabel
Prevention and treatment of acute GvHD.
@en
Prevention and treatment of acute GvHD.
@nl
P2093
P2860
P356
P1476
Prevention and treatment of acute GvHD.
@en
P2093
EBMT Paediatric Working Party
V de Fazio
P2860
P2888
P304
P356
10.1038/BMT.2008.57
P407
P478
41 Suppl 2
P577
2008-06-01T00:00:00Z